newsfilter
← Latest News
Business Wire·

Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

EndeavorRxⓇ prescriptions increased 37% in Q4 2022 over Q3 2022 and 166% in FY 2022 over FY 2021; initial sales force gaining traction and Company is expanding to new U.S. territories Strong clinical data in